TLR4 triggers signaling cascades involving IκB phosphorylation and NF-κB-mediated inflammatory responses, which promotes hepatic fibrosis and drives MASLD progression to NASH and HCC [144]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.